University of Nebraska Medical Center University of Nebraska Med Ctr — Omaha, Nebraska

University of Nebraska Medical Center University of Nebraska Med Ctr is a clinical research site located in Omaha, Nebraska, United States 68198.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Nebraska Medical Center University of Nebraska Med Ctr has participated in 1 clinical trials.

Therapeutic areas: Chronic Myelogenous Leukemia in Chronic Phase.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Nebraska Medical Center University of Nebraska Med Ctr?

University of Nebraska Medical Center University of Nebraska Med Ctr has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Nebraska Medical Center University of Nebraska Med Ctr conducted?

University of Nebraska Medical Center University of Nebraska Med Ctr has 1 clinical trials on record. Their work covers Chronic Myelogenous Leukemia in Chronic Phase.

Is University of Nebraska Medical Center University of Nebraska Med Ctr accredited by Crixeo Clinical Trials?

University of Nebraska Medical Center University of Nebraska Med Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Nebraska Medical Center University of Nebraska Med Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.